Blue Jet Healthcare Limited reported a strong performance for the quarter ended June 30, 2025 (Q1 FY26), driven by robust revenue growth, higher operating efficiency, and improved margins.
The company’s revenue from operations stood at ₹354.76 crore, more than double from ₹162.90 crore in the same quarter last year — registering a 118% year-on-year (YoY) growth. Including other income of ₹8.25 crore, the total income rose to ₹363.01 crore, compared to ₹171.61 crore in Q1 FY25.
On profitability, EBITDA surged to ₹121 crore, up 174% YoY from ₹44.2 crore a year earlier. The EBITDA margin improved significantly to 34.11%, from 27.17% in Q1 FY25, supported by operating leverage and better cost control.
Profit before tax (PBT) rose to ₹122.86 crore, compared to ₹49.47 crore last year. After a tax expense of ₹31.69 crore, net profit came in at ₹91.17 crore, more than doubling from ₹37.77 crore in Q1 FY25.
Total expenses for the quarter were ₹240.15 crore, higher than ₹122.15 crore last year, mainly on account of higher material costs and work-in-progress inventory.
Key Financial Metrics (₹ crore)
| Metric | Q1 FY26 (Jun 2025) | Q1 FY25 (Jun 2024) | YoY Growth |
|---|---|---|---|
| Revenue from Operations | ₹354.76 | ₹162.90 | +118% |
| Total Income | ₹363.01 | ₹171.61 | +111% |
| EBITDA | ₹121 | ₹44.2 | +174% |
| EBITDA Margin (%) | 34.11% | 27.17% | +694 bps |
| Profit Before Tax (PBT) | ₹122.86 | ₹49.47 | +148% |
| Net Profit | ₹91.17 | ₹37.77 | +141% |
